Mirxes Holding Company Limited (SEHK: 2629)
Health Care · Biotechnology · SG
HK$12.41
-20.24% today · -76.8% 1Y
Mirxes Holding Company Limited (SEHK: 2629) operates in the Biotechnology industry within the Health Care sector. The company is valued at $467.25M and employs 352 people.
Over the last twelve months the share price has lost 76.8%, trading between 12.28 and 56.70.
Tweenvest scores Mirxes Holding Company Limited across four factors: quality 12/100. Its strongest factor is quality.
2629 price history
Key figures
- Market cap
- $467.25M
- Revenue (TTM)
- $21.19M
- P/E
- —
- EPS
- -5.97
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$56.70
- 52-week low
- HK$12.28
- Avg volume (3M)
- —
- Shares outstanding
- 295.19M
- Employees
- 352
- Next earnings
- —
About Mirxes Holding Company Limited
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.
- ISIN
- KYG6152E1052
- Founded
- 2014
- Listed since
- May 23, 2025
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Neurogene Inc.NasdaqGM: NGNE | $474.67M | $22.93 | -0.91% |
| DiaMedica Therapeutics Inc.NasdaqCM: DMAC | $474.29M | $8.79 | -5.79% |
| Shattuck Labs, Inc.NasdaqGS: STTK | $473.57M | $4.65 | -3.33% |
| Kamada Ltd.TASE: KMDA | $470.78M | ₪26.23 | 0.00% |
| Medigen Vaccine Biologics CorporationTPEX: 6547 | $466.89M | NT$46.85 | +0.11% |
| MiMedx Group, Inc.NasdaqCM: MDXG | $464.04M | $3.18 | 0.00% |
| Thalys Medical Technology Group CorporationSHSE: 603716 | $462.69M | CN¥13.91 | -2.59% |
| Assembly Biosciences, Inc.NasdaqGS: ASMB | $460.74M | $22.50 | +5.68% |